JA Dormandy, B Charbonnel, DJ Eckland, E Erdmann, M Massi-Benedetti, IK Moules, AM Skene, MH Tan, PJ Lefebvre, GD Murray, E Standl, RG Wilcox, L Wilhelmsen, J Betteridge, K Birkeland, A Gol.......
Hopital Bichat, Service de Diabetologie et d"Endocrinologie, Paris, France. michel.marre@bch.ap-hop-paris.fr OBJECTIVES: To test whether microalbuminuria in patients with type 2 diabetes and hypertension is.....
The FIELD study investigators* SummaryBackground: Patients with type 2 diabetes mellitus are at increased risk of cardiovascular disease, partly owing to dyslipidaemia, which can be amenable to fibr.....
Context β-Blockers have been shown to decrease cardiovascular risk in patients with hypertension and type 2 diabetes mellitus (DM); however, some components of the metabolic syndrome are worsened by some β-blockers.Ob.....